Bioline Rx (BLRX) P/E (2011 - 2026)
Bioline Rx (BLRX) P/E from Jul 27, 2011 to Jul 21, 2026. The TTM Bioline Rx (BLRX) P/E is -1.39. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Bioline Rx (BLRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.39 | +14.07% |
| 2025 | -1.22 | -71.99% |
| 2024 | -4.34 | -86.37% |
| 2023 | -31.87 | +166.10% |
| 2022 | -11.98 | -71.08% |
| 2021 | -41.41 | -19.05% |
| 2020 | -51.16 | +51.59% |
| 2019 | -33.75 | -58.65% |
| 2018 | -81.60 | -47.21% |
| 2017 | -154.57 | +16.54% |
| 2016 | -132.64 | -25.51% |
| 2015 | -178.06 | -8.93% |
| 2014 | -195.52 | +35.25% |
| 2013 | -144.56 | -111.82% |
| 2012 | 1.22K | +511.17% |
| 2011 | 200.12 | N/A |
Comparison Bioline Rx (BLRX) P/E with competitors
Bioline Rx (BLRX) P/E is -1.39.